drugset / Trial / NCT01111331
Drug Drug Interaction of Empagliflozin (BI 10773) and Warfarin in Healthy Volunteers
RandomizedCrossoverOpen-labelTreatment
Summary
The objective of the current study is to investigate the bioavailability of BI 10773 and of warfarin after concomitant multiple oral administration of BI 10773 and a single oral dose of warfarin in comparison to BI 10773 and warfarin given alone, and to investigate the pharmacodynamics of a single oral dose of warfarin with and without concomitant multiple oral administration of BI 10773.
Timeline
- Start
- 2010-05
- Primary completion
- 2010-07
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Empagliflozin | Small molecule | 25 mg | Oral |
| Subject | Warfarin | Small molecule | 25 mg | Oral |
Indications
No indication recorded.